Full-Time

Software Engineer – New Grad

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Entry

Burlingame, CA, USA

Hybrid position in Burlingame, CA.

Category
Full-Stack Engineering
Software Engineering
Requirements
  • Have experience writing production code and driving internship and school projects to completion
  • Interested in learning more about drug discovery and machine learning
Responsibilities
  • Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows
  • Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction
  • Help scale our data infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to enhance the drug discovery process and contribute to the development of new therapies.

Company Stage

Series B

Total Funding

$256.1M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

21%

1 year growth

49%

2 year growth

132%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a 'Fierce 15' company and one of America's most promising AI companies highlights Genesis Therapeutics' industry leadership and innovation.
  • The $200M Series B funding will enable the company to advance its AI-enabled pipeline into clinical development, potentially leading to groundbreaking new treatments.
  • Partnerships with industry giants like NVIDIA and Eli Lilly provide substantial opportunities for growth and collaboration.

What critics are saying

  • The highly competitive biotech and AI-driven drug discovery sectors may pose challenges in maintaining a unique market position.
  • Dependence on strategic partnerships and funding rounds could impact financial stability if future deals or investments do not materialize.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics leverages a unique combination of 3D spatial graph modeling and advanced molecular simulation, setting it apart from traditional drug discovery methods.
  • Their AI platform, GEMS, is capable of generating novel drug-like molecules and making rapid, accurate predictions for challenging targets, which is a significant competitive advantage.
  • Strategic partnerships with major pharmaceutical companies like Eli Lilly and significant funding rounds, including a $200M Series B, underscore their strong market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program